4.38
price up icon3.55%   0.15
pre-market  시장 영업 전:  4.13   -0.25   -5.71%
loading

Monte Rosa Therapeutics Inc 주식(GLUE)의 최신 뉴스

pulisher
Aug 09, 2025

Monte Rosa Therapeutics (GLUE) Reports Q2 Loss, Tops Revenue Estimates - MSN

Aug 09, 2025
pulisher
Aug 09, 2025

Monte Rosa Therapeutics Second Quarter 2025 Earnings: Beats Expectations - Yahoo Finance

Aug 09, 2025
pulisher
Aug 09, 2025

How Monte Rosa Therapeutics Inc. stock performs during market volatilityDownside Risk Evaluation and Stock Analysis - Newser

Aug 09, 2025
pulisher
Aug 08, 2025

Monte Rosa Therapeutics: Q2 Earnings Snapshot - Connecticut Post

Aug 08, 2025
pulisher
Aug 08, 2025

Monte Rosa Therapeutics Reports Q2 2025 Earnings - TipRanks

Aug 08, 2025
pulisher
Aug 07, 2025

Statistical indicators supporting Monte Rosa Therapeutics Inc.’s strengthDaily Pick Forecast with Entry Zones - Newser

Aug 07, 2025
pulisher
Aug 07, 2025

Buy Rating for Monte Rosa Therapeutics: Promising Pipeline and Strategic Partnerships Drive Growth Potential - TipRanks

Aug 07, 2025
pulisher
Aug 07, 2025

Monte Rosa Therapeutics Inc reports results for the quarter ended June 30Earnings Summary - TradingView

Aug 07, 2025
pulisher
Aug 07, 2025

Monte Rosa Therapeutics earnings beat by $0.02, revenue topped estimates - Investing.com Canada

Aug 07, 2025
pulisher
Aug 07, 2025

Monte Rosa (GLUE) Q2 Revenue Jumps 394% - The Globe and Mail

Aug 07, 2025
pulisher
Aug 07, 2025

Monte Rosa Therapeutics reports Q2 revenue $23.194M, consensus $7.37M - TipRanks

Aug 07, 2025
pulisher
Aug 07, 2025

Monte Rosa Therapeutics, Inc. SEC 10-Q Report - TradingView

Aug 07, 2025
pulisher
Aug 07, 2025

Monte Rosa Therapeutics Announces Second Quarter 2025 Financial Results and Business Updates - GlobeNewswire

Aug 07, 2025
pulisher
Aug 06, 2025

How institutional ownership impacts Monte Rosa Therapeutics Inc. stockEarly Entry Ideas with Momentum Potential - Newser

Aug 06, 2025
pulisher
Aug 04, 2025

What are Monte Rosa Therapeutics Inc. company’s key revenue driversAchieve breakthrough gains with smart trades - Jammu Links News

Aug 04, 2025
pulisher
Aug 03, 2025

Should you hold or exit Monte Rosa Therapeutics Inc. nowSector Rotation Strategy for Smart Traders - Newser

Aug 03, 2025
pulisher
Aug 03, 2025

Should I hold or sell Monte Rosa Therapeutics Inc. stock in 2025Achieve breakthrough investment performance - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

How does Monte Rosa Therapeutics Inc. generate profit in a changing economySky-high return potential - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What institutional investors are buying Monte Rosa Therapeutics Inc. stockConsistent wealth multiplication - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

How strong is Monte Rosa Therapeutics Inc. company’s balance sheetMaximize your portfolio’s growth potential - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

Does Monte Rosa Therapeutics Inc. stock perform well during market downturnsHigh-octane gains - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What drives Monte Rosa Therapeutics Inc. stock priceOutstanding capital appreciation - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What catalysts could drive Monte Rosa Therapeutics Inc. stock higher in 2025Unlock daily market insights for better trades - Jammu Links News

Aug 03, 2025
pulisher
Aug 02, 2025

How does Monte Rosa Therapeutics Inc. compare to its industry peersFree High-Return Strategy Alerts - Jammu Links News

Aug 02, 2025
pulisher
Aug 01, 2025

Options Data Show Bullish Bias in Monte Rosa Therapeutics Inc.Pattern Detection for Entry Confirmation Enabled - metal.it

Aug 01, 2025
pulisher
Jul 31, 2025

Sector ETF performance correlation with Monte Rosa Therapeutics Inc.Price Movement and Market Sentiment Analysis - Newser

Jul 31, 2025
pulisher
Jul 31, 2025

GLUE’s Stock Market Adventure: 19.49% YTD Growth Amidst Volatility - investchronicle.com

Jul 31, 2025
pulisher
Jul 31, 2025

Will Monte Rosa Therapeutics Inc. bounce back from current supportFree Chart Breakout Buy Signal Detection - Newser

Jul 31, 2025
pulisher
Jul 30, 2025

How to integrate Monte Rosa Therapeutics Inc. into portfolio analysis toolsEarnings Based Stock Performance Forecast - Newser

Jul 30, 2025
pulisher
Jul 29, 2025

What makes Monte Rosa Therapeutics Inc. stock price move sharplyLow Risk High Return Opportunities Identified - metal.it

Jul 29, 2025
pulisher
Jul 29, 2025

Real time scanner hits for Monte Rosa Therapeutics Inc. explainedBuy Signal System Based on Price Action - Newser

Jul 29, 2025
pulisher
Jul 29, 2025

Monte Rosa Therapeutics Inc. Rebound Backed by Sentiment Shift - metal.it

Jul 29, 2025
pulisher
Jul 29, 2025

Can Monte Rosa Therapeutics Inc. Regain Lost Ground This QuarterLow Risk High Return Opportunities Identified - metal.it

Jul 29, 2025
pulisher
Jul 28, 2025

Monte Rosa Therapeutics Inc. Company Revenue and Profit Trends: A Deep DiveShort Term Risk Controlled Alerts - metal.it

Jul 28, 2025
pulisher
Jul 28, 2025

Sector ETF performance correlation with Monte Rosa Therapeutics Inc. Daily Entry Opportunity Forecasting Tool - Newser

Jul 28, 2025
pulisher
Jul 28, 2025

Monte Rosa Therapeutics Inc. Enters Reversal Setup in Weekly ChartsReal-Time Market Sentiment Tracking Gains Momentum - beatles.ru

Jul 28, 2025
pulisher
Jul 28, 2025

Real time scanner hits for Monte Rosa Therapeutics Inc. explained Chart Pattern Recognition for Profit Timing - Newser

Jul 28, 2025
pulisher
Jul 28, 2025

Is Monte Rosa Therapeutics Inc. a Top Dividend Stock to Watch in 2025Consistent Win Signals - metal.it

Jul 28, 2025
pulisher
Jul 28, 2025

Why Monte Rosa Therapeutics Inc. stock attracts strong analyst attention Free Accurate Buy Point for Momentum Stocks - Newser

Jul 28, 2025
pulisher
Jul 27, 2025

What are the technical indicators suggesting about Monte Rosa Therapeutics Inc.Consistent high-yield stocks - Jammu Links News

Jul 27, 2025
$78.39
price up icon 0.24%
$37.58
price up icon 1.54%
$109.55
price up icon 0.23%
$28.66
price up icon 2.10%
$111.66
price up icon 0.28%
biotechnology ONC
$288.18
price down icon 3.39%
자본화:     |  볼륨(24시간):